---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-086689"
form_type: "8-K"
ticker: "KNSA"
cik: "0001730430"
company_name: "Kiniksa Pharmaceuticals International, plc"
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:36:02.102648+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Kiniksa posts September 2025 investor presentation, no material new information disclosed

## Summary
- Investor presentation posted on investors.kiniksa.com on September 3, 2025.
- Presentation expected to be used in meetings with investors and analysts.
- No financial results, guidance, or specific corporate events announced in the filing.

## SEC filing metadata
- accession: 0001104659-25-086689
- form_type: 8-K
- ticker: KNSA
- cik: 0001730430
- company_name: Kiniksa Pharmaceuticals International, plc
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730430/000110465925086689/0001104659-25-086689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730430/000110465925086689/tm2525025d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-086689
- JSON: https://secwatch.observer/filing/0001104659-25-086689.json
- Plain text: https://secwatch.observer/filing/0001104659-25-086689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.